tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Compare Royalty Pharma (RPRX) vs. Competitors

Compare
1,295 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Royalty Pharma
$40.41
$23.52B
23.30
26.52%
2 Buy
0 Hold
0 Sell
Moderate Buy
Incyte
$101.18
$20.31B
16.97
38.32%
7 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$467.30
$20.53B
17.71
26.01%
5 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$222.45
$14.59B
-52.38
71.95%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$32.93
$21.27B
13.87
68.18%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$116.16
$28.70B
-44.18
-6.55%
12 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RPRX
Royalty Pharma
40.41
9.60
31.16%
INCY
Incyte
101.18
27.41
37.16%
UTHR
United Therapeutics
467.30
115.00
32.64%
ASND
Ascendis Pharma
222.45
95.15
74.74%
GMAB
Genmab
32.93
13.12
66.23%
BNTX
BioNTech SE
116.16
-4.72
-3.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts